Background: Venous thromboembolism (VTE) is a common complication among patients
with cancer. Patients with cancer and VTE are at a markedly increased risk for morbidity and …

Thrombophilia Testing and Venous Thrombosis | New England Journal of Medicine Skip to
main content Access provided by Charite - Universitaetsmedizin Berlin The New England …

PURPOSE To conduct an update of the ASCO venous thromboembolism (VTE) guideline.
METHODS After publication of potentially practice-changing clinical trials, identified through …

PURPOSE To provide updated recommendations about prophylaxis and treatment of
venous thromboembolism (VTE) in patients with cancer. METHODS PubMed and the …

Background Ambulatory patients receiving systemic cancer therapy are at varying risk for
venous thromboembolism. However, the benefit of thromboprophylaxis in these patients is …

Background Patients with active cancer have an increased risk of venous thromboembolism,
which results in substantial morbidity, mortality, and health care expenditures. The Khorana …

Two randomized trials in cancer patients evaluating DOACs have been reported [6, 7].
HOKUSAI Cancer was an open-label, non-inferiority trial that randomized 1050 patients with …

Background: The risk of arterial thromboembolism in patients with cancer is incompletely
understood. Objectives: The authors aimed to better define this epidemiological relationship …

Cancer-associated thrombosis (CAT) is a condition in which relevance has been
increasingly recognised both for physicians that deal with venous thromboembolism (VTE) …

We aimed to evaluate the performance of the Khorana score in predicting venous
thromboembolic events in ambulatory cancer patients. Embase and MEDLINE were …